Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock-Reference-Cited by-同舟云学术

Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock

Published:2017-10 Issue:7 Volume:120 Page:1090-1097
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Jäntti Toni,Tarvasmäki Tuukka,Harjola Veli-Pekka,Parissis John,Pulkki Kari,Sionis Alessandro,Silva-Cardoso Jose,Køber Lars,Banaszewski Marek,Spinar Jindrich,Fuhrmann Valentin,Tolonen Jukka,Carubelli Valentina,diSomma Salvatore,Mebazaa Alexandre,Lassus Johan,Koniari Katerina,Voumvourakis Astrinos,Karavidas Apostolos,Sans-Rosello Jordi,Vila Montserrat,Duran-Cambra Albert,Metra Marco,Bulgari Michela,Lazzarini Valentina,Parenica Jiri,Stipal Roman,Ludka Ondrej,Palsuva Marie,Ganovska Eva,Kubena Petr,Lindholm Matias G.,Hassager Christian,Bäcklund Tom,Jurkko Raija,Järvinen Kristiina,Nieminen Tuomo,Pulkki Kari,Soininen Leena,Sund Reijo,Tierala Ilkka,Tolonen Jukka,Varpula Marjut,Korva Tuomas,Pitkälä Anne,Marino Rossella,Sousa Alexandra,Sousa Carla,Paiva Mariana,Rangel Inês,Almeida Rui,Pinho Teresa,Maciel Maria Júlia,Stepinska Janina,Skrobisz Anna,Góral Piotr

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program;Allen;Eur J Heart Fail,2009

2. Interactions of the heart and the liver;Møller;Eur Heart J,2013

3. Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study;van Deursen;J Card Fail,2014

4. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure;Nikolaou;Eur Heart J,2013

5. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program;Metra;J Am Coll Cardiol,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extra-cardiac management of cardiogenic shock in the intensive care unit;The Journal of Heart and Lung Transplantation;2024-07

2. Cytoprotection as an Innovative Therapeutic Strategy to Cardiogenic Shock: Exploring the Potential of Cytidine-5-Diphosphocholine to Mitigate Target Organ Damage;Journal of Vascular Research;2024

3. Advanced Metrics and Early Predictors of Cardiogenic Shock;Cureus;2023-11-01

4. Organ dysfunction, injury, and failure in cardiogenic shock;Journal of Intensive Care;2023-06-29

5. Criteria for Defining Stages of Cardiogenic Shock Severity;Journal of the American College of Cardiology;2022-07